Cell proliferation, apoptosis, and expression of Bcl-2 and Bax in non-lactating human breast epithelium in relation to the menstrual cycle and reproductive history

Breast Cancer Research and Treatment

Volumn 77, Issue 1, 2003, Pages 37-48

  Feuerhake, F ^a,d   Sigg, W ^b   Hofter E A ^c   Unterberger, P ^b   Welsch, U ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Human; Ki 67; Resting mammary gland; TUNEL

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CELL STRUCTURE; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACTATION; LUTEAL PHASE; MENSTRUAL CYCLE; NICK END LABELING; PARITY; PREMENOPAUSE; PRIORITY JOURNAL; REGULATORY MECHANISM; REPRODUCTION;

ADOLESCENT; AGE FACTORS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST; CELL DIVISION; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LACTATION; MENSTRUAL CYCLE; MIDDLE AGED; PARITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; REPRODUCTIVE HISTORY;

EID: 0037263265     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021119830269     Document Type: Article

References (33)

1. Ferguson DJ, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
2. Ferguson DJ: An ultrastructural study of mitosis and cytokinesis in normal 'resting' human breast. Cell Tissue Res 252: 581-587, 1988
3. Anderson TJ, Battersby S, King PJ, McPherson K, Going JJ: Oral contraceptive use influences resting breast proliferation. Hum Pathol 20: 1139-1144, 1989
4. Olsson H, Jernstrom H, Alm P, Kreipe H, Ingvar C, Jonsson P-E, Ryden S: Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 40: 187-196, 1996
5. Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L: Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176: 123-128, 1997
6. Merlo GR, Cella N, Hynes NE: Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ 8: 251-260, 1997
7. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145: 1323-1336, 1994
8. Reed JC: Balancing cell life and death: Bax, apoptosis and breast cancer. J Clin Invest 97: 2403-2404, 1996
9. Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci Suppl 18: 51-55, 1994
10. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993
11. Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994
12. Feuerhake F, Sigg W, Hofter EA, Dimpfl T, Welsch U: Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium. Cell Tissue Res 299: 47-58, 2000
13. Ferrieres G, Cuny M, Simony-Lafontaine J, Jaquemier J, Rouleau C, Guilleux F, Grenier J, Rouanet P, Pujol H, Jeanteur P, Escot C: Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol 183: 204-211, 1997
14. Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A, Poitout P: Bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1-6, 1994
15. Anderson TJ, Ferguson DJ, Raab GM: Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46: 376-382, 1982
16. Going JJ, Anderson TJ, Battersby S, MacIntyre CC: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193-204, 1988
17. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170, 1988
18. Bai M, Agnatis NJ, Kamina S, Demou A, Zagorianakou P, Katsaraki A, Kanavaros P: In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res 3: 276-283, 2001
19. Colditz GA, Rosner B: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 152: 950-964, 2000
20. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer risk. Bull World Health Organ 43: 209-221, 1970
21. Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A, MacMahon B: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151: 715-722, 2000
22. Newcomb PA, Sorer BE, Longnecker MP, Mittendorf R, Greenberg R, Clapp RW, Burke KP, Willet WC, MacMahon B: Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330: 81-87, 1994
23. Zheng T, Duan L, Zhang B, Wang Y, Chen Y, Zhang Y, Owens PH: Lactation reduces breast cancer risk in Shandong Province, China. Am J Epidemiol 152: 1129-1135, 2000
24. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 11,755-11,759, 2001
25. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525, 1999
26. Potten CS: What is an apoptotic index measuring? A commentary. Br J Cancer 74: 1743-1748, 1996
27. Strange R, Metcalfe T, Thackray L, Dang M: Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 52: 171-181, 2001
28. Chepko G, Smith GH: Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29: 239-253, 1997
29. Stirling JW, Chandler JA: The fine structure of ducts and subareolar ducts in the resting gland of the female breast. Virchows Arch A Pathol Anat Histol 373: 119-132, 1977
30. Stirling JW, Chandler JA: The fine structure of the normal, resting terminal ductal-lobular unit of the female breast. Virchows Arch A Pathol Anat Histol 372: 205-226, 1976
31. Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G: Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 106: 1209-1220, 2000
32. Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen H-J: FasL:Fas ratio - a prognostic factor in breast carcinomas. Cancer Res 60: 822-828, 2000
33. Herrnring C, Reimer T, Jeschke U, Makovitzki J, Kruger K, Gerber B, Kabelitz D, Friese K: Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast rumors. Histochem Cell Biol 113: 189-194, 2000